Chromadex Corporation Announces Executive Changes
California. She is a Chartered Financial Analyst (CFA) and member of the CFA Society of Los Angeles. In On August 8, 2022, the Board appointed Hamed Shahbazi as a member of the Board effective as of August 9, 2022,
to serve until the Company's 2023 annual meeting of stockholders and until his successor is duly elected and qualified. Mr. Shahbazi, 47, serves as Chief Executive Officer and Chairman of the Board at WELL Health
Technologies Corp. Prior to this, he spent twenty years as Chief Executive Officer at TIO Networks Corp. where he also served as Chairman of the Board. Mr. Shahbazi has been appointed to the Nominating and Corporate Governance Committee of the Board. The Board has determined that Mr. Shahbazi is an independent director under the listing standards of the Nasdaq Stock Market LLC and is independent" as defined in 5605(a)(2) of the Securities Exchange Act of 1934, as amended.